Effects of histone deacetylase inhibitor oxamflatin on in vitro porcine somatic cell nuclear transfer embryos. 2014

Liming Hou, and Fanhua Ma, and Jinzeng Yang, and Hasan Riaz, and Yongliang Wang, and Wangjun Wu, and Xiaoliang Xia, and Zhiyuan Ma, and Ying Zhou, and Lin Zhang, and Wenqin Ying, and Dequan Xu, and Bo Zuo, and Zhuqing Ren, and Yuanzhu Xiong
1 Key Laboratory of Agriculture Animal Genetics, Breeding and Reproduction, College of Animal Science, Huazhong Agricultural University , Wuhan, 430070, China .

Low cloning efficiency is considered to be caused by the incomplete or aberrant epigenetic reprogramming of differentiated donor cells in somatic cell nuclear transfer (SCNT) embryos. Oxamflatin, a novel class of histone deacetylase inhibitor (HDACi), has been found to improve the in vitro and full-term developmental potential of SCNT embryos. In the present study, we studied the effects of oxamflatin treatment on in vitro porcine SCNT embryos. Our results indicated that the rate of in vitro blastocyst formation of SCNT embryos treated with 1 μM oxamflatin for 15 h postactivation was significantly higher than all other treatments. Treatment of oxamflatin decreased the relative histone deacetylase (HDAC) activity in cloned embryos and resulted in hyperacetylation levels of histone H3 at lysine 9 (AcH3K9) and histone H4 at lysine 5 (AcH4K5) at pronuclear, two-cell, and four-cell stages partly through downregulating HDAC1. The suppression of HDAC6 through oxamflatin increased the nonhistone acetylation level of α-tubulin during the mitotic cell cycle of early SCNT embryos. In addition, we demonstrated that oxamflatin downregulated DNA methyltransferase 1 (DNMT1) expression and global DNA methylation level (5-methylcytosine) in two-cell-stage porcine SCNT embryos. The pluripotency-related gene POU5F1 was found to be upregulated in the oxamflatin-treated group with a decreased DNA methylation tendency in its promoter regions. Treatment of oxamflatin did not change the locus-specific DNA methylation levels of Sus scrofa heterochromatic satellite DNA sequences at the blastocyst stage. Meanwhile, our findings suggest that treatment with HDACi may contribute to maintaining the stable status of cytoskeleton-associated elements, such as acetylated α-tubulin, which may be the crucial determinants of donor nuclear reprogramming in early SCNT embryos. In summary, oxamflatin treatment improves the developmental potential of porcine SCNT embryos in vitro.

UI MeSH Term Description Entries
D004248 DNA (Cytosine-5-)-Methyltransferases Enzymes that catalyzes the transfer of a methyl group from S-ADENOSYLMETHIONINE to the 5-position of CYTOSINE residues in DNA. DNA (Cytosine-5-)-Methyltransferase,DNA Cytosine-5-Methylase,DNA (Cytosine 5) Methyltransferase,Cytosine-5-Methylase, DNA,DNA Cytosine 5 Methylase
D004622 Embryo, Mammalian The entity of a developing mammal (MAMMALS), generally from the cleavage of a ZYGOTE to the end of embryonic differentiation of basic structures. For the human embryo, this represents the first two months of intrauterine development preceding the stages of the FETUS. Embryonic Structures, Mammalian,Mammalian Embryo,Mammalian Embryo Structures,Mammalian Embryonic Structures,Embryo Structure, Mammalian,Embryo Structures, Mammalian,Embryonic Structure, Mammalian,Embryos, Mammalian,Mammalian Embryo Structure,Mammalian Embryonic Structure,Mammalian Embryos,Structure, Mammalian Embryo,Structure, Mammalian Embryonic,Structures, Mammalian Embryo,Structures, Mammalian Embryonic
D006657 Histones Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each. Histone,Histone H1,Histone H1(s),Histone H2a,Histone H2b,Histone H3,Histone H3.3,Histone H4,Histone H5,Histone H7
D006877 Hydroxamic Acids A class of weak acids with the general formula R-CONHOH. Hydroxamic Acid,Acid, Hydroxamic,Acids, Hydroxamic
D000107 Acetylation Formation of an acetyl derivative. (Stedman, 25th ed) Acetylations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014404 Tubulin A microtubule subunit protein found in large quantities in mammalian brain. It has also been isolated from SPERM FLAGELLUM; CILIA; and other sources. Structurally, the protein is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to COLCHICINE; VINCRISTINE; and VINBLASTINE. alpha-Tubulin,beta-Tubulin,delta-Tubulin,epsilon-Tubulin,gamma-Tubulin,alpha Tubulin,beta Tubulin,delta Tubulin,epsilon Tubulin,gamma Tubulin
D015971 Gene Expression Regulation, Enzymologic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in enzyme synthesis. Enzymologic Gene Expression Regulation,Regulation of Gene Expression, Enzymologic,Regulation, Gene Expression, Enzymologic
D050814 Octamer Transcription Factor-3 An octamer transcription factor that is expressed primarily in totipotent embryonic STEM CELLS and GERM CELLS and is down-regulated during CELL DIFFERENTIATION. Oct-3 Transcription Factor,Transcription Factor Oct-3,Oct-4 Transcription Factor,Octamer-Binding Protein 4,POU Domain, Class 5, Transcription Factor 1,POU5F1 Transcription Factor,Transcription Factor Oct-4,Oct 3 Transcription Factor,Oct 4 Transcription Factor,Oct-3, Transcription Factor,Oct-4, Transcription Factor,Octamer Binding Protein 4,Octamer Transcription Factor 3,Transcription Factor Oct 3,Transcription Factor Oct 4,Transcription Factor, Oct-3,Transcription Factor, Oct-4,Transcription Factor, POU5F1,Transcription Factor-3, Octamer
D053652 Nuclear Transfer Techniques Methods of implanting a CELL NUCLEUS from a donor cell into an enucleated acceptor cell. Nuclear Transplantation,Somatic Cell Nuclear Transfer Technique,Nuclear Transfer Technique,Transplantation, Nuclear

Related Publications

Liming Hou, and Fanhua Ma, and Jinzeng Yang, and Hasan Riaz, and Yongliang Wang, and Wangjun Wu, and Xiaoliang Xia, and Zhiyuan Ma, and Ying Zhou, and Lin Zhang, and Wenqin Ying, and Dequan Xu, and Bo Zuo, and Zhuqing Ren, and Yuanzhu Xiong
October 2012, Cellular reprogramming,
Liming Hou, and Fanhua Ma, and Jinzeng Yang, and Hasan Riaz, and Yongliang Wang, and Wangjun Wu, and Xiaoliang Xia, and Zhiyuan Ma, and Ying Zhou, and Lin Zhang, and Wenqin Ying, and Dequan Xu, and Bo Zuo, and Zhuqing Ren, and Yuanzhu Xiong
December 2011, Cellular reprogramming,
Liming Hou, and Fanhua Ma, and Jinzeng Yang, and Hasan Riaz, and Yongliang Wang, and Wangjun Wu, and Xiaoliang Xia, and Zhiyuan Ma, and Ying Zhou, and Lin Zhang, and Wenqin Ying, and Dequan Xu, and Bo Zuo, and Zhuqing Ren, and Yuanzhu Xiong
February 2010, Cellular reprogramming,
Liming Hou, and Fanhua Ma, and Jinzeng Yang, and Hasan Riaz, and Yongliang Wang, and Wangjun Wu, and Xiaoliang Xia, and Zhiyuan Ma, and Ying Zhou, and Lin Zhang, and Wenqin Ying, and Dequan Xu, and Bo Zuo, and Zhuqing Ren, and Yuanzhu Xiong
January 2017, Theriogenology,
Liming Hou, and Fanhua Ma, and Jinzeng Yang, and Hasan Riaz, and Yongliang Wang, and Wangjun Wu, and Xiaoliang Xia, and Zhiyuan Ma, and Ying Zhou, and Lin Zhang, and Wenqin Ying, and Dequan Xu, and Bo Zuo, and Zhuqing Ren, and Yuanzhu Xiong
January 2014, Theriogenology,
Liming Hou, and Fanhua Ma, and Jinzeng Yang, and Hasan Riaz, and Yongliang Wang, and Wangjun Wu, and Xiaoliang Xia, and Zhiyuan Ma, and Ying Zhou, and Lin Zhang, and Wenqin Ying, and Dequan Xu, and Bo Zuo, and Zhuqing Ren, and Yuanzhu Xiong
April 2011, In vitro cellular & developmental biology. Animal,
Liming Hou, and Fanhua Ma, and Jinzeng Yang, and Hasan Riaz, and Yongliang Wang, and Wangjun Wu, and Xiaoliang Xia, and Zhiyuan Ma, and Ying Zhou, and Lin Zhang, and Wenqin Ying, and Dequan Xu, and Bo Zuo, and Zhuqing Ren, and Yuanzhu Xiong
March 2014, Theriogenology,
Liming Hou, and Fanhua Ma, and Jinzeng Yang, and Hasan Riaz, and Yongliang Wang, and Wangjun Wu, and Xiaoliang Xia, and Zhiyuan Ma, and Ying Zhou, and Lin Zhang, and Wenqin Ying, and Dequan Xu, and Bo Zuo, and Zhuqing Ren, and Yuanzhu Xiong
January 2017, PloS one,
Liming Hou, and Fanhua Ma, and Jinzeng Yang, and Hasan Riaz, and Yongliang Wang, and Wangjun Wu, and Xiaoliang Xia, and Zhiyuan Ma, and Ying Zhou, and Lin Zhang, and Wenqin Ying, and Dequan Xu, and Bo Zuo, and Zhuqing Ren, and Yuanzhu Xiong
February 2003, The Japanese journal of veterinary research,
Liming Hou, and Fanhua Ma, and Jinzeng Yang, and Hasan Riaz, and Yongliang Wang, and Wangjun Wu, and Xiaoliang Xia, and Zhiyuan Ma, and Ying Zhou, and Lin Zhang, and Wenqin Ying, and Dequan Xu, and Bo Zuo, and Zhuqing Ren, and Yuanzhu Xiong
December 2013, Asian-Australasian journal of animal sciences,
Copied contents to your clipboard!